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Occupational asthma can be induced by a number of chemicals at the workplace. Risk assessment of
potential sensitizers is mostly performed in animal experiments. With increasing public demand for
alternative methods, human precision-cut lung slices (PCLS) have been developed as an ex vivo model.
Human PCLS were exposed to increasing concentrations of 20 industrial chemicals including 4 respira-
tory allergens, 11 contact allergens, and 5 non-sensitizing irritants. Local respiratory irritation was
characterized and expressed as 75% (EC25) and 50% (EC50) cell viability with respect to controls.
Dose–response curves of all chemicals except for phenol were generated. Local respiratory inﬂammation
was quantiﬁed by measuring the production of cytokines and chemokines. TNF-a and IL-1a were
increased signiﬁcantly in human PCLS after exposure to the respiratory sensitizers trimellitic anhydride
(TMA) and ammonium hexachloroplatinate (HClPt) at subtoxic concentrations, while contact sensitizers
and non-sensitizing irritants failed to induce the release of these cytokines to the same extent. Interest-
ingly, signiﬁcant increases in TH1/TH2 cytokines could be detected only after exposure to HClPt at a
subtoxic concentration.
In conclusion, allergen-induced cytokines were observed but not considered as biomarkers for the dif-
ferentiation between respiratory and contact sensitizers. Our preliminary results show an ex vivo model
which might be used for prediction of chemical-induced toxicity, but is due to its complex three-dimen-
sional structure not applicable for a simple screening of functional and behavior changes of certain cell
populations such as dendritic cells and T-cells in response to allergens.
 2014 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Asthma is one of the most common chronic inﬂammatory lung
diseases based on a hypersensitivity reaction to environmental
stimuli such as proteins or chemical xenobiotics (Martinez, 2007;
Di et al., 2011). It is characterized by recurrent attacks of breath-
lessness and wheezing, reversible airﬂow obstruction and bron-
chial spasm, supported by the presence of inﬂammatory cells
such as eosinophils, allergen-speciﬁc TH2 lymphocytes, and
activated dendritic cells (DCs) or mast cells (Galli, 1997; Lane
and Lee, 1996; Leckie et al., 2000; NHLBI Guideline, 2007). These
immune cells produce inﬂammatory mediators includingcytokines and chemokines, thereby perpetuating the inﬂammatory
process. In bronchial asthma, cytokines such as TNF-a, interleukin
(IL)-1, IL-4, IL-5, and IL-13 are produced, for example, by DCs
supporting the inﬂammation and the allergen-speciﬁc TH2
response (Dearman et al., 2005). Additionally, chemokines such
as eotaxin, IL-8, RANTES, and MCP-1 are released to elevate the
migration of further immune cells which keep the allergic reaction
and its symptoms going (Wong et al., 2005).
Occupational asthma (OA) is deﬁned as asthma initiated by
workplace exposures (Bernstein, 2003; Cromwell et al., 1979; Wild
and Lopez, 2003; Tarlo and Liss, 2003; Zeiss, 2002; Di Stefano et al.,
2004). This includes development or exacerbations of pre-existing
asthma (Mapp et al., 1999; Holsapple et al., 2006). The onset of the
disease can be induced by industrial high-molecular-weight
(HMW) substances such as proteins or polysaccharides (Wild and
Lopez, 2003), low-molecular-weight (LMW) chemicals, or metals
(Bernstein, 2003; Di Stefano et al., 2004). LMW chemicals play an
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to cause respiratory allergy in humans (Zhang et al., 2009, 2002).
These include platinum compounds (e.g. ammonium hexachloro-
platinate) (Ban et al., 2010), reactive dyes, and acid anhydrides
(e.g., trimellitic anhydride). LMW chemicals mostly act as haptens
due to their small size (e.g. anhydrides). They become allergenic
after conjugation with native carrier proteins (e.g. human serum
albumin) to form a complete antigen which is able to provoke a
speciﬁc immune response (Sastre et al., 2003). Additionally, the
sensitization process is also associated with irritating capabilities
of the chemical. In this case, the disease is referred to as irritant-
induced asthma, which on the one hand can be induced by
repeated-dose application of low doses of irritants or on the other
hand by high doses of irritants where the exposures are in the
irritant dose range (Verstraelen et al., 2008; Brooks and Bernstein,
2011).
Due to increasing incidences of OA induced by LMW agents, the
imperative emerged to identify LMW chemicals which could trig-
ger a sensitization at workplaces, in particular with regard to risk
assessment (Malo and Chan-Yeung, 2009; Orriols et al., 2006). To
date, risk assessment of potentially sensitizing chemicals plays
an important role in the registration of chemicals to protect human
health. At present, the local lymph node assay (LLNA) and the gui-
nea pig maximization tests are used for the detection of sensitizers
(OECD Guideline 429, 2010; Basketter et al., 2002; Magnusson and
Kligman, 1969). Originally, these assays were designed for predict-
ing skin sensitizers, however, most respiratory sensitizers tested
have also been shown to be positive (Boverhof et al., 2008). It
appears that respiratory allergens can induce sensitization when
applied topically to the skin (Hilton et al., 1998). In the modiﬁed
LLNA, referred to as respiratory LLNA (which so far has not been
validated), chemicals are inhaled, and enhanced proliferation of
lymphocytes as well as the cytokine proﬁle in the draining lymph
nodes can be used to identify and distinguish strong contact and
respiratory sensitizers (Basketter and Scholes, 1992; Arts et al.,
2008; Kimber et al., 2007; Van Och et al., 2002; de Jong et al.,
2009; OECD Guideline 429, 2010).
However, there are currently no accepted and validated test
methods to identify chemicals with a potential to cause respiratory
sensitization (van Loveren et al., 2008; Kimber et al., 1996; Holsap-
ple et al., 2006). It is also clear that the use of animal models has
limitations, because of the physiological and biochemical dissimi-
larities (Hartung, 2009). Moreover, in the context of REACH (Euro-
pean Community regulation for the Registration, Evaluation,
Authorisation and Restriction of Chemicals) (Foth and Hayes,
2008) and the principle of the 3Rs (Vitale et al., 2009), there is an
increasing public and legal demand for alternative methods. Since
July 2013 Regulation (EC) No 1223/2009 of the European Parlia-
ment and of the Council on cosmetic products provides the prohi-
bition of animal testing on cosmetic compounds which should be
fully replaced by alternative methods (European Parliament,
2009). Therefore, further models are required which can be used
to assess the sensitizing potential of work-related agents. In partic-
ular, new human-relevant in vitromodels are needed which repro-
duce the acute cell responses to sensitizers and allow a distinction
between respiratory allergens and contact allergens.
Human precision-cut lung slices (PCLS) are an ex vivo model
consisting of all relevant cell types of the respiratory tract situated
in their microanatomical environment (De Kanter et al., 2002;
Henjakovic et al., 2008b). PCLS are well-established in pharmaco-
logical testing and thus offer the opportunity to gain insight into
chemical-induced effects in lung tissue (Henjakovic et al.,
2008a,b; Switalla et al., 2010). Furthermore, lung tissue models
have also been used for research on xenobiotic metabolism (De
Kanter et al., 2004; Umachandran et al., 2004), the early allergicresponse (Wohlsen et al., 2003), and calcium signaling (Bergner
and Sanderson, 2002).
The present study using the ex vivo model PCLS was part of the
European Union project Sens-it-iv, which involved 28 partners
from across Europe. The overall goal of Sens-it-iv was to develop
strategies to replace animal testing by alternative methods for risk
assessment of potential skin or lung sensitizers for the chemical
and cosmetics industries. The goal in our workgroup was to devel-
op and establish an alternative strategy using the ex vivo technique
PCLS for the analysis of effects after acute exposure to chemicals.
Since some chemical-induced irritations may also induce sensitiza-
tion in skin or lung tissue, both irritation and inﬂammation after
submerged exposure to chemicals were assessed by a variety of
immunotoxic endpoints. Therefore, human PCLS were exposed to
LMW chemicals, including respiratory sensitizers, contact sensitiz-
ers and non-sensitizing irritants. Chemical-induced toxicity, result-
ing in 50% and 75% of viability (EC50 and EC25) compared to vehicle
control, was calculated for all chemicals investigated. In order to
compare the data of chemical-induced toxicity ex vivo to in vitro
and in vivo situations, EC25 values of human PCLS were correlated
on the one hand with in vitro data published for THP-1 and NCTC
cell lines, which have different inspects of monocyte-derived cells
and skin-derived epithelial cells, and on the other hand with LD50
values from in vivo rat inhalation studies, which could be interest-
ing for in vivo dose-ﬁnding studies. Furthermore, the initial
response to respiratory and contact allergens was marked ﬁrstly
by the coordinated release of pro-inﬂammatory mediators such
as TNF-a and IL-1a at subtoxic concentrations. Secondly, local
responses of T cells in patient lung tissue were determined by ana-
lyzing TH1/TH2 cytokine release for the identiﬁcation of respiratory
and contact sensitizers.
The present paper describes the performance of tests for the
irritant potency and sensitization potential of a selection of LMW
allergens in human PCLS and compares the results with data
obtained in different cell models and with data from in vivo tests
retrieved from online databases.2. Materials and methods
2.1. Human lung explant culture
Human lung explants were obtained from male and female
patients who underwent lung resection for cancer at Oststadt-
Krankenhaus, Hanover, Germany. All patients gave written con-
sent. The performance with human lung tissue was approved by
the ethics committee of the Hanover Medical School. Only lung
tissue containing no tumors as qualiﬁed by medical pathologists
was used for the experiments. Tissue was processed immediately
on the day of resection as described below. The age of patients
was 60 ± 10 years, and 80% of them were smokers.2.2. Media, reagents and chemicals
Dulbecco’s Modiﬁed Eagle’s Medium Nutrient Mixture F-12
Ham (DMEM) with L-glutamine, 15 mM HEPES without phenol
red, pH 7.2–7.4 was supplied by Sigma Aldrich (Munich, Germany)
and supplemented with 7.5% w/v sodium bicarbonate, without
fetal calf serum. Medium for cultivation was prepared with penicillin
and streptomycin (Sigma Aldrich, Munich, Germany). Low-melting
agarose, Earle’s Balanced Salt Solution (EBSS), Triton X-100,
dimethyl sulfoxide (DMSO), and protease inhibitor cocktail were
also purchased from Sigma Aldrich (Munich, Germany). PBS
(0.1 M sodium phosphate and 0.15 M NaCl, without Ca2+ and
Mg2+) was obtained from Lonza (Verviers, Belgium). Enzyme-linked
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R&D Systems (Wiesbaden-Nordenstadt, Germany). WST-1 assay
was purchased from Roche (Mannheim, Germany). BCA Protein
Assay Kit was obtained from Pierce (Rockford, IL, USA). MSD
96-Well MULTI-ARRAY and MULTI-SPOT were purchased from
Meso Scale Discovery (Gaithersburg, Maryland, USA).
2.3. Preparation of PCLS and tissue cultures
Human lung slices were prepared as described before (Ressmeyer
et al., 2006; Wohlsen et al., 2003; Switalla et al., 2010). In brief,
human lung lobes were ﬁrstly cannulated with a ﬂexible catheter
and the selected lung segments were inﬂated with 1.5% low-
melting agarose medium solution. The inﬂated lungs were imme-
diately solidiﬁed on ice. After polymerization the tissue was cut
into 1-cm-thick slices. Tissue cores were stamped and cut into
approx. 250-lm-thick sections in EBSS using a special microtome
(Krumdieck tissue slicer; Alabama Research and Development,
Munford, AL, USA). Tissue slices were washed and incubated in
DMEM containing 100 U/mL penicillin and 100 lg/mL streptomy-
cin. PCLS were cultured at 37 C, 5% CO2, and 90–95% air humidity
under cell culture conditions and used for experiments as
described below.
The following acceptance criteria were used to control the qual-
ity of the tissue: (i) only lung tissue containing no tumors as qual-
iﬁed by medical pathologists was used, (ii) the tissue was
sufﬁciently viable [WST-1 assay: minimum OD of the mean (dupli-
cate-averaged) tissue control (incubated only with medium) or
vehicle control had to be 0.6.], (iii) the tissue was sufﬁciently sen-
sitive to a toxicant (1% Triton X-100), iv) the tissue was sufﬁciently
sensitive to 100 ng/mL LPS which had to result in an increase of
pro-inﬂammatory cytokine IL-1a to minimum of 150% compared
to untreated control, (v) and most importantly the tissue was sen-
sitive to a positive treatment control. Therefore, 50 lg/mL dexa-
methasone were used. The results of an individual donor were
only excepted if dexamethasone decreased LPS-induced IL-1a to
baseline levels.
2.4. Incubation of PCLS with chemicals
PCLS were incubated with 20 chemicals selected within the
Sens-it-iv consortium, including 4 respiratory allergens: trimellitic
anhydride (TMA), ammonium hexachloroplatinate (HClPt), maleic
anhydride (MA), and glutaraldehyde (GA); 11 contact allergens:
1,2-dibromo-2,4-dicyannobutane (2-Bro), cinnamic aldehyde
(CinAld), cinnamic alcohol (CinOH), 2,4-dinitrochlorobenzene
(DNCB), eugenol (Eug), p-phenylenediamine (PPD), resorcinol
(Res), tetramethylthiuramdisulﬁde (TMTD), glyoxal (Glyo), 2-mer-
captobenzothiazole (2-Mer), and 4-nitrobenzyl bromide (4-Nit);
and 5 non-sensitizing irritants: phenol (Phe), lactic acid (LA),
salicilic acid (SA), sodium lauryl sulfate (SLS), and glycerol (Glyc).
Sections were incubated with the chemicals diluted in DMEM at
37 C, 5% CO2 and 90–95% air humidity under standard submerged
cell culture conditions. Lung slices without addition of chemicals
were incubated as negative control. Each chemical was tested in
at least 3 biological donors (biological replicates) in ﬁve increasing
concentrations. Within one run, every concentration of a chemical
was tested at once. The number of slices obtained from one donor
was sufﬁcient to test the entire range of concentrations of a chem-
ical, including all technical duplicates and controls. After 24 h total
incubation time, cell culture supernatants as well as the PCLS tis-
sue were analyzed. The supernatant was collected for extrinsic
cytokine and chemokine determination. To this end, 0.2% protease
inhibitor cocktail was added to the supernatant. PCLS were either
used for WST-1 assay or for determination of intrinsic cytokine lev-
els and protein content. For protein and intracellular cytokine mea-surement the tissue was permeabilized with 1% Triton X-100 in
PBS plus 0.2% protease inhibitor cocktail at 37 C for 60 min.
Samples were stored at 80 C and cytokine contents were mea-
sured either by MSD or ELISA.
2.5. Preparation of chemicals
HClPt, GA, CinAld, Res, Glyo, Phe, LA, SLS, and Glyc were
dissolved in sterile pre-warmed (37 C) DMEM. TMA, MA, 2-Bro,
CinOH, DNCB, Eug, PPD, TMTD, 2-Mer, 4-Nit, and SA were dissolved
in DMSO at 100-fold of the desired ﬁnal concentration. The solvent
DMSO was present at a constant volume in the vehicle controls
and in all test concentrations. The highest concentration of test
chemicals was intended to induce a cytotoxic effect of more than
50% dead cells.
2.6. WST-1 reduction
WST-1 Proliferation Assay Kit provides an easy-to-use tool for
studying changes in cell viability. The assay is based on the reduc-
tion of tetrazolium salt WST-1 to soluble formazan in the mito-
chondria of metabolically active cells. The amount of formazan
dye formed directly correlates with the number of metabolically
active cells in the culture. After incubation of PCLS, the medium
was removed and PCLS were incubated for 1 h at 37 C with
0.125 mL freshly prepared WST-1 solution per slice (diluted 1:10
in culture medium). Absorbance of the formazan solution was
determined at 450 nm with a reference wavelength of 630 nm.
2.7. Calcein AM/ethidium homodimer-1 staining
Viability of the tissue slices was directly checked by calcein
acetoxymethyl/ethidium homodimer-1 (calcein AM/EthD-1) stain-
ing (Invitrogen, Karlsruhe, Germany) using a confocal laser scan-
ning microscope Meta 510 (Zeiss, Jena, Germany). Live cells were
distinguished by enzymatic conversion of calcein AM to intensely
green ﬂuorescent calcein. EthD-1 binds to DNA and therefore pro-
duces intracellular orange/red ﬂuorescence in nuclei of dead cells.
Lung slices were incubated with 4 lM calcein AM and 4 lM EthD-1
for 45 min at room temperature. PCLS were washed in DMEM and
investigated by confocal laser scanning microscopy (40 water
immersion objective, excitation wavelengths 488 nm and
543 nm, emission ﬁlters BP 505–550 nm and LP 560 nm, thickness
40 lm). Image stacks of a deﬁned volume were analyzed with
Bitplane IMARIS 7.4.0.
2.8. Quantitative image analysis with IMARIS 7.4.0
Three-dimensional ﬂuorescence images of PCLS were quantita-
tively analyzed with the IMARIS 7.4.0 software. Confocal datasets
with adimensionof 900  900  40 lmwereprocessedvia ‘‘surface
rendering’’, which allowed semi-automated counting of EthD-1-
labeled, red ﬂuorescent nuclei of dead cells. This was achieved by
counting spots P5 lm in diameter. In a second step, the total
volume of the cytoplasm of viable cells was determined by calculat-
ing the full volume of calcein (green) ﬂuorescent structures,
expressed as lm3. Subsequently, the ratio of counted cell nuclei
and volumes of cytoplasm of live cells stained with calcein was cal-
culated. Threshold levels for the calculation of ‘‘surface objects’’ and
‘‘spots’’ were set once for each channel and the same thresholds
were used for all datasets. The viability of PCLS is expressed as the
number of EthD+ red spots/105 lm3 calcein+ green volume.
2.9. ELISA: quantiﬁcation of IL-1a and TNF-a
IL-1a and TNF-a were measured in tissue supernatants and
lysis extracts of PCLS using commercially available enzyme-linked
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den-Nordenstadt, Germany). ELISA was performed according to
the manufacturer’s speciﬁcations. The lower limit of quantiﬁcation
was 31 pg/mL for human TNF-a and IL-1a. Absorbance was deter-
mined at 450 nm with a reference wavelength of 570 nm.
2.10. Measurement of cytokines and chemokines by Meso Scale
Discovery Assays
Levels of cytokines and chemokines were determined in super-
natants and lysis extracts of PCLS exposed to TMA, HClPt, GA,
DNCB, CinAld, 2-Bro, CinOH, SLS, Phe, and LA using MSD technol-
ogy. Here, detection of cytokines is based on the detection of elec-
trochemiluminescence. A 96-well multi-spot plate for the
detection of 8 human cytokines (IFN-c, IL-10, IL-12 p70, IL-13,
IL-1b, IL-2, IL-4, and IL-5) and single-spot plates for the detection
of RANTES and eotaxin, respectively, were obtained from MSD.
The assay was performed according to the manufacturer’s instruc-
tions. Twenty-ﬁve lL of each standard and sample were incubated
for 1.5 h with vigorous shaking (1000 rpm) at room temperature.
Detection antibody solution was dispensed at 25 lL into each well
of the MSD plate. The plate was also incubated for 1.5 h with vig-
orous shaking (1000 rpm) at room temperature. Finally, the plate
was washed three times with PBS + 0.05% Tween-20 and analyzed
immediately after addition of Read Buffer. Calculation of cytokines
was performed using a 4-fold serial diluted standard. Data analysis
was performed using the discovery workbench software.
2.11. Protein determination
Protein concentrations were determined by the BCA method
using bovine serum albumin (BSA) as standard. Twenty-ﬁve lL of
sample or BSA were incubated with 200 lL BCA reagents for
30 min at 37 C. Absorbance was measured at a wavelength of
570 nm.
2.12. Statistical analysis
Data in the ﬁgures are given as means ± SEM. Statistical analysis
was performed by non-parametric t-tests (Mann–Whitney test)
(software: GraphPad Prism 4, version 4.03). Correlation of data
generated in vivo and ex vivo was evaluated using a linear regres-
sion analysis model. Differences between treated samples and con-
trol were considered statistically signiﬁcant at a level of p < 0.05.
2.13. Curve ﬁtting
EC50 (effective concentration at 50% reduction of cell viability)
and EC25 values (effective concentration at 25% reduction of cell
viability) were evaluated for results of WST-1 assay. Data are pre-
sented as mean ± SEM (%) compared to tissue or vehicle control
converted from measured absorbance. Percentage calculations
were normalized and analyzed by ‘‘nonlinear regression’’ using
‘‘sigmoidal dose–response’’ with deﬁned constrains for the deter-
mination of EC50 values and EC25 values (software: GraphPad Prism
4, version 4.03).
3. Results
3.1. Determination of 50% and 75% cell viability in human PCLS
In order to measure chemical-induced cytotoxicity in human
PCLS, viability of the tissue was determined by detection of
released lactate dehydrogenase (LDH) using the LDH assay, by
measurement of metabolic enzyme activity using the WST-1 assay,and by quantitative image analysis of LIVE/DEAD staining. To this
end, tissue sections were incubated with the selected set of chem-
icals for 24 h. Fig. 1 shows examples of the determination of toxic
and subtoxic concentrations obtained in human PCLS after sub-
merged exposure to the respiratory agents HClPt, TMA, GA, and
MA using the LDH (Fig. 1A–D) and WST-1 assays (Fig. 1E–H).
EC50 and EC25 values were evaluated primarily by the results of
the WST-1 assay, since exposure to HClPt, TMA, GA, and MA failed
to increase lactate dehydrogenase release (Fig. 1E–H). In order to
ensure that viability was reliably measured, a microscopy-based
approach was chosen. Therefore, tissue was stained by LIVE/DEAD
staining and images were obtained by confocal laser scanning
microscopy (CLSM). Fig. 1 shows examples of LIVE/DEAD staining
of human PCLS after incubation with HClPt (Fig. 1I), TMA (Fig. 1J),
and GA (Fig. 1K), which resulted in 25% reduction of cell viability in
comparison to respective controls.
Dose–response curves of respiratory allergens (TMA, HClPt, MA,
and GA), contact allergens (2-Bro, CinAld, CinOH, DNCB, Eug, PPD,
Res, TMTD, Glyo, 2-Mer, and 4-Nit), and non-sensitizing irritants
(LA, SA, SLS, and Glyc) were generated by determination of the
number of metabolically active cells in the PCLS using WST-1 assay
(Supplement 2). Concentration-dependent toxicity could be shown
for all tested chemicals, with EC25 values ranging from 0.051 lg/
mL to 1895 lg/mL, and EC50 values ranging from 0.16 lg/mL to
5625 lg/mL except for Phe (Table 1). Thus, the most toxic
substance was Glyo with an EC25 value of 0.051 lg/mL and an
EC50 value of 0.16 lg/mL. The least toxic substance was Res with
an EC25 value of 1895 lg/mL and an EC50 value of 5625 lg/mL.
No dose–response curve could be generated for Phe, since no clear
metabolic reduction of WST-1 was observed. Subtoxic concentra-
tions were conﬁrmed by using LIVE/DEAD staining for CLSM. Sub-
sequently, the microscopic images were analyzed by IMARIS and
the ratio of nuclei of dead cells in relation to the volume of live
cells in human PCLS was quantiﬁed with a maximum concentra-
tion of 250 lg/mL exposed to Phe (Supplement 1).
3.2. Comparison of chemical-induced cytotoxicity in the PCLS model to
other in vitro or in vivo studies
Recently published EC25 values ranging from 5 lg/mL for TMTD
to 500 lg/mL for TMA were calculated from in vitro studies using
the THP-1 cell line, which was exposed to HClPt, TMA, CinAld,
DNCB, PPD, TMTD, Phe, SA, and SLS (Mitjans et al., 2008). Other
recently published EC25 values ranging from 2.5 lg/mL for 4-Nit
to 1000 lg/mL for Res as well as for Glyc were calculated from
the NCTC cell line, which was exposed to HClPt, TMA, CinAld,
CinOH, DNCB, Eug, PPD, Res, TMTD, 2-Mer, 4-Nit, Phe, LA, SA, SLS,
and Glyc (Mitjans et al., 2008; Corsini et al., 2009). Additionally,
in vivo deposited doses converted from LD50 values, ranging from
0.01 mg for Glyo to 19.10 mg for LA published from rat inhalation
toxicity studies (Online databank, 2011), could be used as refer-
ence values for the correlation with EC50 values of human PCLS
(Table 1).
To determine the degree of correlation between the results
obtained in human PCLS and the in vitro ﬁndings, EC25 values of hu-
man PCLS and corresponding EC25 values from data generated with
the human cell line THP-1 exposed to HClPt, TMA, CinAld, DNCB,
Eug, PPD, TMTD, Phe, SA, and SLS and the human cell line NCTC
exposed to HClPt, TMA, CinAld, CinOH, DNCB, Eug, PPD, Res, TMTD,
2-Mer, 4-Nit, Phe, LA, SA, SLS, and Glyc were entered in linear
regression analysis models. Individual EC25 values of human PCLS
correlated signiﬁcantly with data from the THP-1 and NCTC cell
lines (Pearson r = 0.86 and 0.78; p-value = 0.0033 and 0.0004,
respectively) (Fig. 2A and B).
In the same way as the comparison with the in vitro ﬁndings,
EC50 values of human PCLS were also entered in linear regression
Fig. 1. Toxic and subtoxic concentrations of respiratory agents as shown here for HClPt, TMA, GA, and MA were determined in human PCLS by measurement of (A–D) released
LDH [n = 5(HClPt, TMA, GA), n = 3MA]; (E–H) reduced mitochondrial activity using WST-1 assay (n = 16HClPt, n = 9TMA, n = 7GA, and n = 4MA). LIVE/DEAD staining of human PCLS for
confocal microscopy after exposure to HClPt, TMA, and GA (no picture was taken for MA). Tissue sections were stained with calcein AM/EthD-1 after incubation with (I) 66 lg/
mL HClPt, (J) 256 lg/mL TMA, (K) 19 lg/mL GA, (L) without chemicals (tissue control), or (M) after cell lysis (Triton X-100 for positive control). Fluorescent staining in PCLS
was analyzed by confocal laser scanning microscopy (20 objective, excitation wavelengths 488 nm and 543 nm, emission ﬁlters BP 505–550 nm and LP 560 nm, thickness
circa 30 lm, grid spacing = 50 lm).
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from the online databank including values where the LD50 is likely
to be greater than the highest tested dose (Online databank, 2011)
for HClPt, TMA, MA, GA, Eug, Res, PPD, TMTD, Glyo, 2-Mer, Phe, LA,
SA, and Glyc, with Pearson r = 0.70 (p-value = 0.0052) (Fig. 2C).
3.3. Respiratory allergens TMA and HClPt signiﬁcantly increase pro-
inﬂammatory cytokines TNF-a and IL-1a in human PCLS
In the present study, respiratory sensitizers (TMA, HClPt, GA,
and MA), contact sensitizers (DNCB, 2-Bro, CinAld, CinOH, 2-Mer,
and 4-Nit), and non-sensitizing irritants (Phe, LA, and SLS) were
investigated for their ability to induce an acute inﬂammatory
response by cytokine release in human PCLS (Figs. 3 and 4). Two
or three subtoxic concentrations (approximating EC25 values) were
selected for 24-h submerged exposure under standard cell culture
conditions. The respiratory sensitizers TMA and HClPt induced a
dose-dependent and signiﬁcant increase in IL-1a by up to 855%
and 338%, respectively (Fig. 3A and B), whereas GA and MA failed
to induce IL-1a (Fig. 3C and D). The respiratory sensitizers HClPt
and GA induced dose-dependent and signiﬁcant production of
TNF-a, increased by up to 440% and 241%, respectively (Fig. 4B
and C), whereas TMA and MA failed to induce TNF-a (Fig. 4A and
D). The contact sensitizers (DNCB, 2-Bro, CinAld, CinOH, 2-Mer,
and 4-Nit) and the non-sensitizing irritants (Phe, LA, and SLS) failed
to induce any of the pro-inﬂammatory cytokines IL-1a and TNF-a
(Figs. 3E–L and 4E–L).
3.4. Production of TH1/TH2 cytokines induced by respiratory allergens
(TMA and HClPt) in human PCLS in comparison to contact allergens
(2-Bro and CinAld) and non-sensitizing irritants (Phe and SLS)
In the present study, human PCLS were incubated with either
respiratory sensitizers, contact sensitizers, or non-sensitizingirritants to test the effect on TH1/TH2 cytokine production in
human PCLS as an approach mimicking the in vivo situation (Van
Och et al., 2002). Total IL-10 production was signiﬁcantly increased
(3.0-fold) after exposure to both respiratory allergens TMA and
HClPt (Fig. 5A). Furthermore, signiﬁcant increases after exposure
to HClPt could be detected for IL-2 with up to 1420%, for IL-13 with
up to 1320%, for IL-5 with up to 620%, and for eotaxin-2 with up to
203% (Fig. 5C–F). However, the TH1 cytokine IFN-c was also signif-
icantly induced by HClPt with up to 2810% (Fig. 5B). The contact
allergens 2-Bro and CinAld as well as the negative controls Phe
and SLS did not induce production of IL-10, IL-2, IL-13, IL-5,
eotaxin-2, and IFN-c (Fig. 5).
3.5. Different levels of cytokine production induced by HClPt in human
and mouse PCLS
Both human and mouse PCLS were exposed under submerged
conditions for 24 h to HClPt at subtoxic concentrations of 64 lg/
mL and 32 lg/mL, respectively. Extracellular and intracellular pro-
duction of IFN-c, IL-10, IL-8, TNF-a, RANTES, eotaxin-2, and IL-1a
were determined. Cytokine and chemokine levels were repre-
sented percentage-wise to compare the expression in human and
mouse PCLS. Signiﬁcant increases could be detected for IFN-c with
up to 4237%, RANTES with up to 530%, and eotaxin-2 with up to
251% in human PCLS after exposure to 64 lg/mL HClPt in compar-
ison with mouse PCLS after exposure to 32 lg/mL HClPt. Total IL-
10, IL-8, TNF-a, and IL-1a production was increased by up to
257%, 166%, 149%, and 270%, respectively, in human PCLS exposed
to 64 lg/mL HClPt compared to mouse PCLS exposed to 32 lg/mL
HClPt (Supplement 3).
4. Discussion
The present study addressed two major issues: Firstly, acute
chemical-induced respiratory injury was assessed by determination
Table 1
Human PCLS were exposed to 20 chemicals including 4 respiratory allergens, 11 contact allergens, and 5 non-sensitizing irritants under submerged conditions for 24-h in serum-
free DMEM. EC25 (effective concentration at 25% reduction of cell viability) and EC50 (effective concentration at 50% reduction of cell viability) values of chemicals were calculated
on the basis of dose–response curves assessed by WST-1 reduction (Supplement 2). EC25 values published for a human promyelocytic cell line (THP-1) and a human keratinocyte
cell line (NCTC), and LD50 values from published data of inhalation studies with rats exposed to the same chemicals were found (online databanks: ChemIDplus Lite, TOXNET, and
NIOSH Pocket Guide to Chemical Hazards). The deposited doses were calculated. abbr: abbreviation; inhal: inhalation.
Chemical
abbr.
Chemical name Category Human PCLS EC25
(lg/mL)
Human PCLS EC50
(lg/mL)
THP-1 EC25
(lg/mL)
NCTC EC25
(lg/mL)
Rat inhal LD50
(mg/m3)
Rat inhal deposited
dose (mg)
HCIPt Ammonium
hexachloroplatinate
Respiratory
allergen
66 193 15 15 565/8 h 1.36
GA Glutaraldehyde Respiratory
allergen
19 58 Unknown Unknown 480/4 h 1.15
TMA Trimellitic anhydride Respiratory
allergen
256 761 >500 >500 >2330/4 h 5.60
MA Maleic anhydride Respiratory
allergen
188 576 Unknown Unknown >4350/4 h 10.45
2-Bro 1,2-Dibromo-2,4-
dicyanobutane
Contact
allergen
8.1 24 Unknown Unknown Unknown Unknown
CinAld Cinnamaldehyde Contact
allergen
48 147 20 40 Unknown Unknown
CinOH Cinnamyl alcohol Contact
allergen
97 286 Unknown 300 Unknown Unknown
DNCB 2,4-
Dinitrochlorobenzene
Contact
allergen
1.7 5.2 5 5 Unknown Unknown
Eug Eugenol Contact
allergen
55 159 Unknown 225 2580/4 h 6.20
PPD p-Phenylenediamine Contact
allergen
12 36 22 108 920/4 h 2.21
Res Resorcinol Contact
allergen
1895 5625 Unknown >1000 >7800/4 h 18.75
TMTD Tetramethylthiuram
disulﬁde
Contact
allergen
6 19 5 32 500/4 h 1.20
Glyo Glyoxal Contact
allergen
0.051 0.16 Unknown Unknown 2.440/4 h 0.01
2-Mer 2-
Mercaptobenzothiazole
Contact
allergen
32 93 Unknown 125 1270/4 h 3.05
4-Nit 4-Nitrobenzyl bromide Contact
allergen
0.6 1.9 Unknown 2.5 Unknown Unknown
Phe Phenol Irritant >250 >250 70 70 316/4 h 0.76
LA Lactic acid Irritant 256 761 Unknown >500 7940/4 h 19.10
SA Salicylic acid Irritant 200 585 250 250 900/1 h 2.16
SLS Sodium dodecyl sulfate Irritant 19 55 30 30 Unknown Unknown
Glyc Glycerol Irritant 25 77 Unknown >1000 570/1h 1.37
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results clearly showed that toxicity was concentration-depen-
dently induced by nearly all tested chemicals, leading to cell death
or tissue injury in lung parenchyma. Secondly, chemical-induced
inﬂammation in human PCLS was assessed by measurement of
pro-inﬂammatory and TH1/TH2 cytokines at subtoxic concentra-
tions. Here, it was assumed primarily that these cytokines/chemo-
kines could initially be released, for example, by activated resident
macrophages, mucosal dendritic cells and structural cells such as
ﬁbroblasts, epithelial cells, and endothelial cells which subse-
quently could inﬂuence T cell activation and differentiation occur-
ring at the ﬁrst contact with potential sensitizers. Although
manifestation of the sensitization process after uptake of allergens
in the lungs and migration of antigen-presenting cells to the lymph
nodes cannot be mimicked in live lung sections due to missing
connections to the blood and lymph system, the onset of the pro-
cess is orchestrated by cytokines and chemokines which indeed
can be induced in PCLS (Switalla et al., 2010).
Inhalation of chemicals can induce respiratory irritation,
inﬂammation, and sensitization (Wanner et al., 2010; Calzetta
et al., 2011). In case of a single exposure to high levels of an irritat-
ing chemical, an immediate response of the nervous system pre-
vents tissue damage (Mariussen, 2012). Nevertheless, health
outcomes after long-term exposure to low levels of a chemical
can be even worse (Brimﬁeld, 2012). In the present study, we
determined the cytotoxicity of 20 selected case chemicals inhuman lung tissue after acute exposure (Table 1). Chemical-
induced toxicity with a minimum reduction of viability by 25%
was observed in human PCLS with all chemicals except phenol.
The most toxic chemical was glyoxal, which is known to attack
amino groups of proteins, nucleotides and lipids. This leads to
inactivation of enzymes, disturbance in the cellular metabolism,
impaired proteolysis, and inhibition of cell proliferation and pro-
tein synthesis (Shangari and O’Brien, 2004). Other chemicals such
as sodium lauryl sulfate, which is used as an anionic detergent, also
induced cell death in human lung tissue. It totally disrupts cell
membranes and denatures proteins at higher concentrations
(Chaturvedi and Kumar, 2011). The least toxic chemical was resor-
cinol with EC25 value of 1895 lg/mL, which is due to its lower
reactivity in aqueous solutions (Hahn, 2006). Some chemicals were
able to change the pH of the medium. However, they were not
neutralized in order to mimic real exposure at workplace. As all
case chemicals were incubated with human PCLS under submerged
conditions, chemicals with limited water solubility such as trimel-
litic anhydride were initially dissolved in the solvent DMSO. The
solvent was not toxic at the ﬁnal concentration used, but an inﬂu-
ence on cells cannot be excluded.
The multicellular microanatomy of PCLS makes this ex vivo
model very attractive for a ﬁrst assessment of acute local respira-
tory toxicity induced by chemicals. Other published studies inves-
tigated cellular responses of single cell lines such as human
keratinocyte cells (NCTC 2455) and human promyelocytic cells
Fig. 2. Correlations were determined between EC25 in human PCLS and (A) the human cell line THP-1 for HClPt, TMA, CinAld, DNCB, Eug, PPD, TMTD, Phe, SA, and SLS with
Pearson’s rank of 0.86, and (B) the human cell line NCTC for HClPt, TMA, CinAld, CinOH, DNCB, Eug, PPD, Res, TMTD, 2-Mer, 4-Nit, Phe, LA, SA, SLS, and Glyc with Pearson’s rank
of 0.78, using a linear regression analysis model. Data of the human cell lines THP-1 and NCTC were taken from Corsini et al. (2009) and Mitjans et al. (2008), respectively.
Correlations were also determined between EC50 in human PCLS and (C) in vivo data taken from online inhalation studies (ChemIDplus Lite, TOXNET, ECHA, and NIOSH Pocket
Guide to Chemical Hazards) with Pearson’s rank of 0.70, using a linear regression analysis model.
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et al., 2009; Mitjans et al., 2008). Comparison of the ex vivo model
with in vitro models showed that the EC25 values in human PCLS
correlated better with the EC25 values in THP-1 cells than in NCTC
cells (Fig. 2), suggesting that cells in human PCLS behave more like
monocyte-derived cells regarding their resistance to chemicals
than skin-derived epithelial cells. Remarkable is the spreading of
the toxicity data, which is less the case for single-cell cultures,
where all EC25 values are very close together. This wide range dis-
tribution can also be observed for in vivo toxicity data of several
inhalation toxicity studies after exposure to the same chemicals.
Here, the most and least toxic chemical were glyoxal and resor-
cinol, which were also found to be the most and least toxic chem-
ical in human lung sections. The less toxic chemicals after testing
in human PCLS were trimellitic anhydride and lactic acid, of which
lactic acid was reported to be the least toxic chemical with about
7940 mg/m3 after 4 h of exposure in rats. Altogether, the toxicity
of chemicals in the human ex vivo model correlated signiﬁcantly
with LD50 values from in vivo rat inhalation studies. However, com-
parison of the toxicological data from animal experiments with
ex vivo data obtained in human tissue remains critical due to differ-
ences in (1) the species used in the models (rodent versus human),
(2) the type of model, with the in vivo models providing organ
functionality but no human physiology and the ex vivo model pro-
viding human physiology but no organ functionality, and (3) the
site of action, which can be different from the site of exposure. Inparticular the site of action versus the site of exposure has to be
taken into consideration. For some inhalable toxicants, the lungs
are the main route of exposure but not the main target and toxicity
is observed mainly in other organs such as liver and kidneys. More-
over, for most chemicals toxicity data for humans are only
available if published in case reports. Although for some chemicals
human toxicity data after acute and chronic exposures of, for
example, workers who had contact with glyoxal are available, the
actual exposure doses are unknown. Hence, whether the obtained
human respiratory toxicity data for the selected chemicals reﬂects
the in vivo situation very closely or not remains highly speculative.
The utility of human PCLS as a prediction model for cytotoxicity
should be part of different in vitro or in vivo models in order to
reﬂect the various toxicological processes (Sauer et al., 2013).
In the second part of our study, human PCLS were exposed
under submerged conditions to chemicals including respiratory
sensitizers (TMA, HClPt, GA, and MA), contact sensitizers (DNCB,
2-Bro, CinAld, CinOH, 2-Mer, and 4-Nit), and non-sensitizing irri-
tants (Phe, LA, and SLS) for 24 h. This incubation of human tissue
with allergens induced production of a variety of cytokines and
chemokines. The early response comprised in particular cytokines
such as TNF-a and IL-1a produced by both inﬂammatory and
structural cells. Of course, this induction of cytokines could be
due to chemical-induced loss of viability, which can be accompa-
nied by the production of pro-inﬂammatory cytokines. Within this
work, however, special attempts were made to use only subtoxic
Fig. 3. Total production of IL-1a induced by the respiratory sensitizers (A) TMA, (B) HClPt, (C) GA, and (D) MA, the contact sensitizers (E) DNCB, (F) 2-Bro, (G) CinAld, (H)
CinOH, and (I) 4-Nit, and the non-sensitizing irritants (J) Phe, (K) LA and (L) SLS in human PCLS after 24-h submerse exposure to two or three subtoxic concentrations. It shows
induction of signiﬁcant increases by the respiratory sensitizers (A) TMA and (B) HClPt. Cytokine levels in culture supernatants and lysates were determined by ELISA. Data for
PCLS are presented as mean ± SEM, n = 3(MA, LA, 4-Nit, CinOH), n = 4GA, n = 52-Bro, n = 9(TMA, SLS, Phe, DNCB), n = 14HClPt, n = 16(CinAld), *p < 0.05; **p < 0.01 (Mann–Whitney test). Sum:
sum of extracellular and intracellular of IL-1a.
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Interestingly, respiratory sensitizers increased TNF-a or IL-1a,
while contact sensitizers and non-sensitizing irritants failed to in-
duce release of these cytokines to the same extent. However, TNF-
a and IL-1a cannot be considered as biomarkers for the differenti-
ation between respiratory and contact sensitizers. There are other
biomarkers such as IL-8 which were already described in recent
publications and were used for identiﬁcation of allergens (Mitjans
et al., 2008). Unfortunately, in human PCLS solvents such as DMSO,
which was mostly used to dissolve respiratory sensitizers, also in-
duced high amounts of IL-8. Thus, IL-8 could not be used for the
screening of potential chemical allergens in human lung tissue.
In this context, we also have to consider that the use of lungs ob-
tained from (i) old donors (60 ± 10 years), and (ii) 80% of whom
were smokers are additional factors to affect the tissue reactivity.
Efforts have been made to guarantee adequate reactivity of the
lung tissue by using e.g. positive controls such as LPS. Here, if the
reactivity of the lung tissue was below 150% compared to non-ex-
posed samples the tissue was not accepted for further evaluation.
Nevertheless, cells that respond to LPS might be others than cells
that respond to allergens. Furthermore, adapted reactions of the
immune system against foreign agents show age-related differ-
ences in mature and young organisms. Adults and young children
are displaying marked differences in the immune system leading
to increased susceptibility of the young organism. Using lung tis-
sue of rather elder people might be a further reason for failure.In conclusion, production of at least one of the pro-inﬂamma-
tory cytokines TNF-a or IL-1a was elevated signiﬁcantly after
exposure to respiratory sensitizers at subtoxic concentrations in
human PCLS. This could inﬂuence the local respiratory cytokine
milieu, leading for example to acute inﬂammation, stimulation of
phagocytosis in macrophages, maturation of DCs, and migration
of cells. As a result, the sensitizers that enter the lungs change
not only the functional and phenotypic behavior of immune cells,
but may also inﬂuence structural cells, leading to diverse effects
such as epithelial changes, increased smooth muscle mass, in-
creased number of activated ﬁbroblasts, and vascular changes
(Araujo et al., 2008; Holgate, 2008). Both inﬂammatory and struc-
tural cells in the airway tissue play an active role in modulating the
immune response and thus in the outcome of the lung immune re-
sponse by release of multiple cytokines, chemokines, and growth
factors (Al-Muhsen et al., 2011).
In case of the onset of an allergic reaction, it has been shown
in vivo that respiratory sensitizers induce predominantly TH2-type
immune responses with cytokine release of IL-4 and IL-10, whereas
contact sensitizers are usually characterized by TH1-type responses
and IFN-c release (Dearman and Kimber, 1999, 1991; de Jong et al.,
2009; Plitnick et al., 2002). In our study, we investigated the re-
lease of cytokines/chemokines (IL-10, IL-2, IL-13, IL-5, IFN-c, and
eotaxin-2) in human lung slices after acute exposure to respiratory
allergens such as trimellitic anhydride and ammonium hexachlo-
roplatinate in comparison to contact allergens and non-sensitizing
Fig. 4. Total production including extracellular and intracellular TNF-a induced by the respiratory sensitizers (A) TMA, (B) HClPt, (C) GA, and (D) MA, the contact sensitizers
(E) DNCB, (F) 2-Bro, (G) CinAld, (H) CinOH, and (I) 4-Nit, the non-sensitizing irritants (J) Phe, (K) LA and (L) SLS in human PCLS after 24-h submerse exposure at two or three
subtoxic concentrations. It shows a signiﬁcant increase induced by the respiratory sensitizers (B) HClPt and (C) GA. Cytokine levels in culture supernatants and lysates were
determined by ELISA. Data for PCLS are presented as mean ± SEM, n = 3(MA, 4-Nit, LA), n = 4(GA, CinOH), n = 62-Bro, n = 8DNCB, n = 9(TMA, Phe, SLS), n = 14HClPt, n = 16CinAld, *p < 0.05;
**p < 0.01 (Mann–Whitney test). Sum: total production of TNF-a.
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could not show a TH2-speciﬁc response after exposure to allergens
such as trimellitic anhydride. One explanation is that trimellitic
anhydride could lose allergenic potential if it is converted to tri-
mellitic acid in aqueous environments (OECD SIDS, 2002). Interest-
ingly, we found that ammonium hexachloroplatinate was able to
induce the TH2-type cytokines IL-5, IL-13, and IL-10 as well as
the TH1-type cytokine IFN-c. It was suspected that the human lung
tissue used had been pre-sensitized by platinum, a well-known
allergen. Platinum group elements are emitted from automobile
exhaust catalysts in the environment and have caused concern
for their environmental and biological accumulation (Ek et al.,
2004; Rauch et al., 2005a,b). To prove our suspicion, extracellular
and intracellular production of IFN-c, IL-10, IL-8, TNF-a, RANTES,
eotaxin-2, and IL-1a were measured in both mouse and human
PCLS (Supplement 3). Again, cytokine release was measured after
exposure to subtoxic concentrations to avoid unspeciﬁc initial in-
crease and later decrease due to loss of cell viability. No increase
in cytokines could be detected in mouse PCLS after 24-h exposure
to ammonium hexachloroplatinate. Since the donors of human
lung material in the present study might already have been
exposed to some of the test substances or components before, as
outlined above for platinum compounds, activation of haptenated
peptide-speciﬁc memory T cells was followed by an increase in
TH1/TH2 cytokines in lung tissue (Schuppe et al., 1998). Production
of pro-inﬂammatory cytokines could be directly induced by recep-
tor-mediated endocytosis of dendritic antigen-presenting cells
(Schuppe et al., 1998). It has also been reported recently that thereare numerous resident memory T cells in human lung tissues
which could respond to re-call antigens (Purwar et al., 2011). This
re-call effect was inducible due to the manifestation of the sensiti-
zation process before. Thus, the sensitization risk from automobile
catalysts in the environment could be regarded as a potential
health concern due to allergenic reactions in susceptible
individuals.
In summary, the underlying mechanisms of chemical-induced
irritation and inﬂammation are diverse and complex and only
partly understood. According to our current understanding, persis-
tent irritation and inﬂammation are intertwined local processes
having a crucial impact on sensitization. In this context, it becomes
obvious that the development of a risk assessment model for
chemical-induced sensitization should be based on the monitoring
of irritation and inﬂammation. Therefore, a tissue culture model
with physiologically highly relevant cell–cell communication
between different cell types for the assessment of irritation and
inﬂammation is needed. For all approaches mentioned above, PCLS
offer a novel and unique way for studying the response of human
lung tissue at the level of protein production, enzyme activities,
and mediator release without animal testing. Furthermore, extrap-
olation of this information to the human in vivo situation is possi-
ble. The high degree of complexity provides a physiologically more
relevant model and circumvents drawbacks of simple single-cell
cultures (Roggen et al., 2006). Within our work, we have shown
that different and intertwined mechanisms of immunotoxicity take
place: (1) a direct toxic effect and (2) an immune-mediated mech-
anism. Nevertheless, as with any other assay for chemical-induced
Fig. 5. Total production of (A) IL-10, (B) IFN-c, (C) IL-2, (D) IL-13, (E) IL-5, and (F) eotaxin-2 induced by the respiratory sensitizers TMA and HClPt, the contact sensitizers
CinAld and 2-Bro, and the non-sensitizing irritants SLS and Phe in human PCLS after 24-h submerse exposure at one subtoxic concentration (TMA 200 lg/mL, HClPt 64 lg/mL,
CinAld 53 lg/mL, 2-Bro 8 lg/mL, SLS 12.5 lg/mL, and Phe 250 lg/mL) and without chemicals (controls with the same dilutions). Cytokine levels in culture supernatants and
lysates were determined by MSD technology. Data for PCLS are presented as mean ± SEM, n = 3, *p < 0.05; **p < 0.01 (Mann–Whitney test). Sum: sum of extracellular and
intracellular cytokine amounts.
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considered.
Limitations of the PCLS model are the following: (i) Trafﬁcking
of cells from blood into the lungs cannot be assessed. Similarly,
migration of cells from the lung into the blood or lymph nodes can-
not be evaluated. Both limit the use of ex vivo lung tissue for the
assessment of adaptive immune responses. (ii) Although PCLS
show good reproducibility of ﬁndings in one assay, variations with-
in human donors are high. These results were to be expected and
reﬂect the genetic diversity of individuals. (iii) Although the tech-
nique is not more cost intensive than other in vitro models it is
clearly limited by availability of human donors. (iv) There are sev-
eral publications reporting the metabolic activation of compounds
(Lake et al., 2003; Pushparajah et al., 2007). Nevertheless,metabolic activation of substances might also be limited. (v) In
the project described here we used a distinctive set of chemicals.
The exposure was done submersely. Whether or not it can be used
for testing of wide range of chemical classes e.g. nanomaterials,
pesticides, metal compounds and other industrial substances
remains open. In particular the use for the testing of nanomaterials
might be limited. Since 2009 it has been studied whether PCLS can
be used for the prediction of chemical-induced toxicity and thereof
applied for replacement of dose range ﬁnding experiments before
in vivo acute inhalation toxicity studies are performed (project
funded by the German Ministry for Education and Research,
project number 0315720 A-C).
In conclusion, allergen-induced cytokines were observed but
not considered as biomarkers for the differentiation between respi-
598 L. Lauenstein et al. / Toxicology in Vitro 28 (2014) 588–599ratory and contact sensitizers. Our preliminary results show an
ex vivo model which might be used for prediction of chemical-
induced toxicity, but is due to its complex three-dimensional
structure not applicable for a simple screening of functional and
behavior changes of cell populations such as dendritic cells and
T-cells although these cells are present in lung section.
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